Denise C. Connolly

Publications

• Miscommunication Involving 'standard Care'. Response to Protocol Review Scenario: Specify All Medications
  Lab Animal. Mar, 2011  |   Pubmed ID: 21326182
• Development of a Syngeneic Mouse Model of Epithelial Ovarian Cancer
  Journal of Ovarian Research. 2010  |   Pubmed ID: 20958993
• Strategies for High-resolution Imaging of Epithelial Ovarian Cancer by Laparoscopic Nonlinear Microscopy
  Translational Oncology. 2010  |   Pubmed ID: 20563260
• Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers
  PloS One. 2010  |   Pubmed ID: 20422001
• Xenograft and Transgenic Mouse Models of Epithelial Ovarian Cancer and Non-invasive Imaging Modalities to Monitor Ovarian Tumor Growth in Situ: Applications in Evaluating Novel Therapeutic Agents
  Current Protocols in Pharmacology / Editorial Board, S.J. Enna (editor-in-chief) ... [et Al.]. Jun, 2009  |   Pubmed ID: 22294392
• Xenograft and Transgenic Mouse Models of Epithelial Ovarian Cancer and Non Invasive Imaging Modalities to Monitor Ovarian Tumor Growth In Situ -Applications in Evaluating Novel Therapeutic Agents
  Current Protocols in Pharmacology / Editorial Board, S.J. Enna (editor-in-chief) ... [et Al.]. Jun, 2009  |   Pubmed ID: 20634901
• Induction of Ovarian Leiomyosarcomas in Mice by Conditional Inactivation of Brca1 and P53
  PloS One. 2009  |   Pubmed ID: 20046879
• Animal Models of Ovarian Cancer
  Cancer Treatment and Research. 2009  |   Pubmed ID: 19763445
• NEDD9 Promotes Oncogenic Signaling in Mammary Tumor Development
  Cancer Research. Sep, 2009  |   Pubmed ID: 19738060
• Expression of Activated PIK3CA in Ovarian Surface Epithelium Results in Hyperplasia but Not Tumor Formation
  PloS One. 2009  |   Pubmed ID: 19172191
• Magnetic Resonance Imaging for Detection and Determination of Tumor Volume in a Genetically Engineered Mouse Model of Ovarian Cancer
  Cancer Biology & Therapy. Nov, 2007  |   Pubmed ID: 17986851
• RAD001 (Everolimus) Delays Tumor Onset and Progression in a Transgenic Mouse Model of Ovarian Cancer
  Cancer Research. Mar, 2007  |   Pubmed ID: 17363557
• Mullerian Inhibiting Substance Enhances Subclinical Doses of Chemotherapeutic Agents to Inhibit Human and Mouse Ovarian Cancer
  Proceedings of the National Academy of Sciences of the United States of America. Nov, 2006  |   Pubmed ID: 17088539
• Recombinant Human Mullerian Inhibiting Substance Inhibits Long-term Growth of MIS Type II Receptor-directed Transgenic Mouse Ovarian Cancers in Vivo
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Mar, 2006  |   Pubmed ID: 16533786
• Cyclooxygenase-1 is Overexpressed in Multiple Genetically Engineered Mouse Models of Epithelial Ovarian Cancer
  Cancer Research. Mar, 2006  |   Pubmed ID: 16510568
• Pathology of Ovarian Neoplasms in Genetically Modified Mice
  Comparative Medicine. Feb, 2004  |   Pubmed ID: 15382342
• Membrane Localization of V-ErbB is Required but Not Sufficient for Ligand-independent Transformation
  Experimental Cell Research. Jun, 2004  |   Pubmed ID: 15149858
• Focus on Epithelial Ovarian Cancer
  Cancer Cell. Jan, 2004  |   Pubmed ID: 14749123
• Female Mice Chimeric for Expression of the Simian Virus 40 TAg Under Control of the MISIIR Promoter Develop Epithelial Ovarian Cancer
  Cancer Research. Mar, 2003  |   Pubmed ID: 12649204
• Activation of Cancer-specific Gene Expression by the Survivin Promoter
  Journal of the National Cancer Institute. Apr, 2002  |   Pubmed ID: 11929953